CD34 and graft versus host disease: To address this major limitation, we have developed an improved humanized mouse model, derived from fresh CD34+ stem cell engraftment in NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice, without the onset of graft-versus-host disease (GVHD).